| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO, Director | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 17 Mar 2026 | 0001106578 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | +9,500 | +23% | $146.03* | 50,013 | 16 Mar 2026 | Direct | F1 | |
| transaction | UTHR | Common Stock | Sale | $190,498 | -360 | -0.72% | $529.16 | 49,653 | 16 Mar 2026 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $106,146 | -200 | -0.4% | $530.73 | 49,453 | 16 Mar 2026 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $299,872 | -564 | -1.1% | $531.69 | 48,889 | 16 Mar 2026 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $850,660 | -1,597 | -3.3% | $532.66 | 47,292 | 16 Mar 2026 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $1,347,998 | -2,526 | -5.3% | $533.65 | 44,766 | 16 Mar 2026 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $950,820 | -1,779 | -4% | $534.47 | 42,987 | 16 Mar 2026 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $830,704 | -1,551 | -3.6% | $535.59 | 41,436 | 16 Mar 2026 | Direct | F1, F8 |
| transaction | UTHR | Common Stock | Sale | $409,341 | -763 | -1.8% | $536.49 | 40,673 | 16 Mar 2026 | Direct | F1, F9 |
| transaction | UTHR | Common Stock | Sale | $85,979 | -160 | -0.39% | $537.37 | 40,513 | 16 Mar 2026 | Direct | F1 |
| holding | UTHR | Common Stock | 166 | 16 Mar 2026 | by Spouse | ||||||
| holding | UTHR | Common Stock | 324,518 | 16 Mar 2026 | by Trust | F10 | |||||
| holding | UTHR | Common Stock | 258,117 | 16 Mar 2026 | by Trust | F11 | |||||
| holding | UTHR | Common Stock | 45,596 | 16 Mar 2026 | by Trust | F12 | |||||
| holding | UTHR | Common Stock | 10,962 | 16 Mar 2026 | by Trust | F13 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | -9,500 | -6.6% | $0.000000* | 135,500 | 16 Mar 2026 | Common Stock | 9,500 | $146.03 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. |
| F2 | This transaction was executed in multiple trades at prices ranging from $528.51 to $529.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $530.03 to $531.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $531.10 to $532.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $532.10 to $533.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $533.12 to $534.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $534.12 to $535.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $535.14 to $536.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $536.16 to $536.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F10 | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F11 | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| F12 | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F13 | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |